Renal transplantation

Risk Stratification for Hepatitis B Virus Reactivation in Kidney Transplant Recipients With Resolved HBV Infection

Early riser specific immune cell response by delayed-type hypersensitivity in a kidney transplant patient vaccinated against COVID-19

Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin – study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients

BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients

BNT162b2 3차 부스터 용량은 신장 이식 수혜자의 RBD IgG 및 중화 항체 모두에 의해 평가된 체액 반응을 상당히 증가시킵니다

Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study

Kidney transplant recipients’ attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance

Antibody response to two doses of inactivated SARS‐CoV‐2 vaccine (CoronaVac) in kidney transplant recipients

Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)

BNT162b2 mRNA SARS-CoV-2 백신의 추가 용량을 2회 백신 용량 후 적절한 체액 반응 없이 신장 이식 수용자에게 투여할 때 면역 억제 감소: 무작위 대조 시험 프로토콜(BECAME 연구)

Follow‐up of renal transplant recipients after acute COVID‐19—A prospective cohort single‐center study

Renal transplantation after recovery from COVID-19 – a case report with implications for transplant programs in the face of the ongoing corona-pandemic

COVID-19에서 회복 후 신장 이식-진행중인 코로나-폴란드에 직면 한 이식 프로그램에 대한 시사점이있는 사례 보고서